Christopher Pittenger

Reversible inhibition of CREB/ATF transcription factors in region CA1 of the dorsal hippocampus disrupts hippocampus-dependent spatial memory.

CREB, memory enhancement and the treatment of memory disorders: promises, pitfalls and prospects.

In search of general mechanisms for long-lasting plasticity: Aplysia and the hippocampus.

[Past and future studies of memory].

A form of long-lasting, learning-related synaptic plasticity in the hippocampus induced by heterosynaptic low-frequency pairing.

Toward a neurobiology of psychotherapy: basic science and clinical applications.

Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial.

N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder.

Initial evidence of the beneficial effects of glutamate-modulating agents in the treatment of self-injurious behavior associated with borderline personality disorder.

Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.

Impaired bidirectional synaptic plasticity and procedural memory formation in striatum-specific cAMP response element-binding protein-deficient mice.

Visual hallucinations from the addition of riluzole to memantine and bupropion.

Beneficial effects of the glutamate-modulating agent riluzole on disordered eating and pathological skin-picking behaviors.

Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with trichotillomania.

Gabapentin abuse, and delirium tremens upon gabapentin withdrawal.

The NMDA receptor as a therapeutic target in major depressive disorder.

Systematic review: pharmacological and behavioral treatment for trichotillomania.

Stress, depression, and neuroplasticity: a convergence of mechanisms.

Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic review.

Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a series of 13 cases, with long-term follow-up.

Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology.

Riluzole in the treatment of mood and anxiety disorders.

Meta-analysis of the symptom structure of obsessive-compulsive disorder.

A double dissociation revealing bidirectional competition between striatum and hippocampus during learning.

Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder.

Inhibition of CREB activity in the dorsal portion of the striatum potentiates behavioral responses to drugs of abuse.

Cued and spatial learning in the water maze: equivalent learning in male and female mice.

Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer's disease mouse model.

Dissociable regulation of instrumental action within mouse prefrontal cortex.

Clinical treatment of obsessive compulsive disorder.

Recent advances in Tourette syndrome.

Epigenetic modification of the BDNF locus by early-life enrichment: towards a molecular correlate of resilience?

High levels of histidine decarboxylase in the striatum of mice and rats.

Association of polymorphisms in HCN4 with mood disorders and obsessive compulsive disorder.

Dimensional correlates of poor insight in obsessive-compulsive disorder.

Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment.

Pathophysiological modeling of obsessive-compulsive disorder: challenges, and progress.